Colgate-Palmolive Co (CL) concluded trading on Thursday at a closing price of $93.56, with 3.43 million shares of worth about $320.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.27% during that period and on December 12, 2024 the price saw a gain of about 0.86%. Currently the company’s common shares owned by public are about 817.01M shares, out of which, 816.09M shares are available for trading.
Stock saw a price change of -1.62% in past 5 days and over the past one month there was a price change of 2.25%. Year-to-date (YTD), CL shares are showing a performance of 17.38% which increased to 19.05% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $75.50 but also hit the highest price of $109.30 during that period. The average intraday trading volume for Colgate-Palmolive Co shares is 4.52 million. The stock is currently trading -1.03% below its 20-day simple moving average (SMA20), while that difference is down -2.44% for SMA50 and it goes to -2.48% lower than SMA200.
Colgate-Palmolive Co (NYSE: CL) currently have 817.01M outstanding shares and institutions hold larger chunk of about 84.30% of that.
The stock has a current market capitalization of $76.44B and its 3Y-monthly beta is at 0.42. PE ratio of stock for trailing 12 months is 26.88, while it has posted earnings per share of $3.48 in the same period. Its PEG reads 3.18 and has Quick Ratio of 0.68 while making debt-to-equity ratio of 19.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CL, volatility over the week remained 1.91% while standing at 1.69% over the month.
Stock’s fiscal year EPS is expected to rise by 10.94% while it is estimated to increase by 7.90% in next year. EPS is likely to grow at an annualized rate of 8.45% for next 5-years, compared to annual growth of 0.18% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on October 28, 2024 offering a Hold rating for the stock and assigned a target price range of between $105 and $101 to it. Coverage by Piper Sandler stated Colgate-Palmolive Co (CL) stock as an Overweight in their note to investors on September 24, 2024, suggesting a price target of $121 for the stock. On September 16, 2024, Wells Fargo Downgrade their recommendations, while on September 09, 2024, Deutsche Bank Downgrade their ratings for the stock with a price target of $109. Stock get a Hold rating from HSBC Securities on July 26, 2024.
